We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
-4%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$362M
Cap. Flow
-$5M
Cap. Flow %
-0.12%
Top 10 Hldgs %
43.71%
Holding
683
New
46
Increased
475
Reduced
93
Closed
17

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$38.3M
2
AMZN icon
Amazon
AMZN
+$27.7M
3
PLTR icon
Palantir
PLTR
+$17.5M
4
HIMS icon
Hims & Hers Health
HIMS
+$13.7M
5
YUMC icon
Yum China
YUMC
+$13.2M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$39.4M
2
NVDA icon
NVIDIA
NVDA
+$30.1M
3
META icon
Meta Platforms (Facebook)
META
+$14.9M
4
BEKE icon
KE Holdings
BEKE
+$14.1M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 42.45%
2 Consumer Discretionary 16.26%
3 Communication Services 14.17%
4 Healthcare 8.06%
5 Consumer Staples 5.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV
526
DELISTED
KalVista Pharmaceuticals
KALV
$14.4K ﹤0.01%
1,247
+224
+22% +$2.29K
CSTL icon
527
Castle Biosciences
CSTL
$813M
$14.3K ﹤0.01%
716
+128
+22% +$3.17K
PGRE
528
DELISTED
Paramount Group
PGRE
$14K ﹤0.01%
3,264
+127
+4% +$574
MGTX icon
529
MeiraGTx Holdings
MGTX
$1.11B
$13.6K ﹤0.01%
2,001
+360
+22% +$2.42K
QURE icon
530
uniQure
QURE
$2.93B
$13.2K ﹤0.01%
1,248
+225
+22% +$3.15K
KURA icon
531
Kura Oncology
KURA
$826M
$13.1K ﹤0.01%
1,991
+358
+22% +$2.79K
PLYM
532
DELISTED
Plymouth Industrial REIT
PLYM
$12.5K ﹤0.01%
766
+29
+4% +$489
GOOD
533
Gladstone Commercial Corp
GOOD
$606M
$12.5K ﹤0.01%
832
+65
+8% +$1.02K
SAGE
534
DELISTED
Sage Therapeutics
SAGE
$12.4K ﹤0.01%
1,566
+282
+22% +$2.06K
TRVI icon
535
Trevi Therapeutics
TRVI
$2.61B
$12.4K ﹤0.01%
1,968
+354
+22% +$1.69K
ARVN icon
536
Arvinas
ARVN
$536M
$12.3K ﹤0.01%
1,759
+316
+22% +$4.95K
OMER icon
537
Omeros
OMER
$863M
$12.2K ﹤0.01%
1,483
+266
+22% +$2.35K
SVRA icon
538
Savara
SVRA
$1.14B
$12.2K ﹤0.01%
4,395
+791
+22% +$2.18K
TYRA icon
539
Tyra Biosciences
TYRA
$1.97B
$12.1K ﹤0.01%
1,296
+233
+22% +$3.02K
DTE icon
540
DTE Energy
DTE
$29.5B
$12K ﹤0.01%
87
-2
-2% -$255
URGN icon
541
UroGen Pharma
URGN
$2B
$11.9K ﹤0.01%
1,080
+194
+22% +$2.07K
HCM icon
542
HUTCHMED
HCM
$1.85B
$11.9K ﹤0.01%
794
+143
+22% +$2.11K
WSR
543
DELISTED
Whitestone REIT
WSR
$11.9K ﹤0.01%
815
+48
+6% +$661
CMS icon
544
CMS Energy
CMS
$22.7B
$11.9K ﹤0.01%
158
-3
-2% -$210
AEE icon
545
Ameren
AEE
$30.1B
$11.8K ﹤0.01%
118
-2
-2% -$193
PPL
546
PPL Corp
PPL
$26.8B
$11.8K ﹤0.01%
327
-7
-2% -$237
NI icon
547
NiSource
NI
$21.6B
$11.6K ﹤0.01%
290
-6
-2% -$231
SITC icon
548
SITE Centers
SITC
$227M
$11.4K ﹤0.01%
885
+35
+4% +$499
CGEM icon
549
Cullinan Oncology
CGEM
$1.08B
$11.3K ﹤0.01%
1,491
+268
+22% +$2.57K
AHRT
550
AH Realty Trust
AHRT
$536M
$11.2K ﹤0.01%
1,496
+59
+4% +$536
20 21
22
23 24

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

GF Fund Management's Q1 2025 Portfolio in Review

As of Q1 2025, GF Fund Management held 683 positions worth $4.26B, down 7.8% from $4.62B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q1 2025 filing shows 46 new, 475 increased, 93 reduced and 17 closed positions. Its largest new stake was Hims & Hers Health: 368,661 shares worth $10.9M. The largest sale was Pinduoduo, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q1 2025 buy was Hims & Hers Health: 368,661 shares worth $10.9M.
  • GF Fund Management added most to Philip Morris in Q1 2025, an estimated $38.3M increase.
  • GF Fund Management's biggest Q1 2025 reduction was Pinduoduo, cutting an estimated $39.4M.
  • GF Fund Management fully exited Applied Optoelectronics in Q1 2025, selling an estimated $5.07M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.26B portfolio in Q1 2025.
  • GF Fund Management opened 46 new positions and closed 17 in Q1 2025.
  • GF Fund Management's portfolio value fell 7.8% quarter-over-quarter to $4.26B.

Based on GF Fund Management's 13F filing for Q1 2025, filed 29 Apr 2025.